Zogenix Inc (USD)
ZGNX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range18.02 | 18.75
52-Wk Range- | -
Last Close18.27
Mkt Cap (m)1,016.87
Dividend yield-
ISINUS98978L2043
Volume518,625.00
Exchange VenueNAS

Company Profile

Zogenix Inc is a pharmaceutical company engaged in commercializing and developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Key Information
Price/Earning-
Price/Book2.41
Price/Sales131.19
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 04/03/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.zogenix.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)27.1828.859.820.003.65-
Operating Income (m)-49.73-62.45-94.24-139.88-172.78-
Net Income (m)26.14-69.71-126.82-123.91-419.50-
Basic EPS1.22-2.81-4.65-3.27-9.74-
Avg. Diluted Shares Outstanding (m)21.4524.7927.3037.8843.08-
Balance Sheet
USD201520162017201820192020
Current Assets (m)184.60119.91304.70532.73287.24-
Non Current Assets (m)121.39111.59112.91115.60127.01-
Total Assets (m)305.99231.51417.61648.33414.25-
Current Liabilities (m)30.0820.3120.9858.3895.39-
Total Liabilities (m)------
Total Equity (m)182.76120.76301.52522.80245.06-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)-64.60-72.88-75.87-111.66-111.52-
Capital Expenditure (m)-0.31-0.10-0.08-1.02-9.49-
Figures are quoted in USD unless stated otherwise
0.13 (0.71%)
$
18.40
Last Price